2020•Journal of Diabetes and its ComplicationsRequires access

Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality

Sidar Çöpür, Emine Meltem Onal, Barış Afşar, Alberto Arduan Ortiz, Daniël H. van Raalte, David Z.I. Cherney, Peter R Rossing, Mehmet Kanbay

Open publisher page 52 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 52 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Glycemic, Fructosamine, Diabetes mellitus, Glycated hemoglobin, Kidney disease, Internal medicine, Context (archaeology)

Back to paper search Browse research topics Original source

Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality — Research Paper | ScholarLens